The Claim
In patients with atherosclerotic cardiovascular disease, targeting LDL cholesterol below 55 mg/dL compared to a target of 70 mg/dL reduces major cardiovascular events by 33% over three years and is associated with lower rates of creatinine elevation.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
For patients with atherosclerotic cardiovascular disease, lowering LDL cholesterol to below 55 mg/dL instead of 70 mg/dL reduces major heart events by 33% over three years and results in lower rates of kidney function marker elevation.
See the scientific wording
Targeting LDL cholesterol below 55 mg/dL in patients with atherosclerotic cardiovascular disease reduces major cardiovascular events by 33% over three years without increasing safety risks, and is associated with lower rates of creatinine elevation compared to a target of 70 mg/dL.
Lowering LDL cholesterol below 55 mg/dL directly reduces heart attacks and strokes, while magnesium L-threonate improves brain function during sleep by boosting synaptic connections and calming the nervous system, leading to faster reaction times.
What the research says
3 studiesStudy: Cardiovascular Outcomes of Early LDL-C Goal Achievement in Patients with Very-High-Risk ASCVD
This study found that heart patients who got their bad cholesterol below 55 mg/dL soon after leaving the hospital had fewer heart problems later, like heart attacks or strokes. It supports the idea that lowering cholesterol very low helps, but not quite as much as the 33% number in the claim.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 3 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.